96 related articles for article (PubMed ID: 15880536)
1. A dendritic tetra(bisphosphonic acid) for improved targeting of proteins to bone.
Bansal G; Wright JE; Kucharski C; Uludağ H
Angew Chem Int Ed Engl; 2005 Jun; 44(24):3710-4. PubMed ID: 15880536
[No Abstract] [Full Text] [Related]
2. Bisphosphonate conjugation to proteins as a means to impart bone affinity.
Uludag H; Kousinioris N; Gao T; Kantoci D
Biotechnol Prog; 2000; 16(2):258-67. PubMed ID: 10753453
[TBL] [Abstract][Full Text] [Related]
3. Targeting systemically administered proteins to bone by bisphosphonate conjugation.
Uludag H; Yang J
Biotechnol Prog; 2002; 18(3):604-11. PubMed ID: 12052079
[TBL] [Abstract][Full Text] [Related]
4. A di(bisphosphonic acid) for protein coupling and targeting to bone.
Bansal G; Gittens SA; Uludağ H
J Pharm Sci; 2004 Nov; 93(11):2788-99. PubMed ID: 15368528
[TBL] [Abstract][Full Text] [Related]
5. A comparison of mineral affinity of bisphosphonate-protein conjugates constructed with disulfide and thioether linkages.
Wright JE; Gittens SA; Bansal G; Kitov PI; Sindrey D; Kucharski C; Uludağ H
Biomaterials; 2006 Feb; 27(5):769-84. PubMed ID: 16055182
[TBL] [Abstract][Full Text] [Related]
6. Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug. I: synthesis and in vivo characterization of osteotropic carboxyfluorescein.
Fujisaki J; Tokunaga Y; Takahashi T; Hirose T; Shimojo F; Kagayama A; Hata T
J Drug Target; 1995; 3(4):273-82. PubMed ID: 8821001
[TBL] [Abstract][Full Text] [Related]
7. Cationic poly-L-lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats.
Boyd BJ; Kaminskas LM; Karellas P; Krippner G; Lessene R; Porter CJ
Mol Pharm; 2006; 3(5):614-27. PubMed ID: 17009860
[TBL] [Abstract][Full Text] [Related]
8. Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug. III: Pharmacokinetics and targeting characteristics of osteotropic carboxyfluorescein.
Fujisaki J; Tokunaga Y; Sawamoto T; Takahashi T; Kimura S; Shimojo F; Hata T
J Drug Target; 1996; 4(2):117-23. PubMed ID: 8894972
[TBL] [Abstract][Full Text] [Related]
9. The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimers.
Kaminskas LM; Boyd BJ; Karellas P; Krippner GY; Lessene R; Kelly B; Porter CJ
Mol Pharm; 2008; 5(3):449-63. PubMed ID: 18393438
[TBL] [Abstract][Full Text] [Related]
10. Sequential growth factor delivery from complexed microspheres for bone tissue engineering.
Basmanav FB; Kose GT; Hasirci V
Biomaterials; 2008 Nov; 29(31):4195-204. PubMed ID: 18691753
[TBL] [Abstract][Full Text] [Related]
11. Imparting mineral affinity to fetuin by bisphosphonate conjugation: a comparison of three bisphosphonate conjugation schemes.
Gittens SA; Bansal G; Kucharski C; Borden M; Uludag H
Mol Pharm; 2005; 2(5):392-406. PubMed ID: 16196492
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate sequestering agents. Synthesis and preliminary evaluation for in vitro and in vivo uranium(VI) chelation.
Sawicki M; Lecerclé D; Grillon G; Le Gall B; Sérandour AL; Poncy JL; Bailly T; Burgada R; Lecouvey M; Challeix V; Leydier A; Pellet-Rostaing S; Ansoborlo E; Taran F
Eur J Med Chem; 2008 Dec; 43(12):2768-77. PubMed ID: 18313802
[TBL] [Abstract][Full Text] [Related]
13. Drug release from hydrogel containing albumin as crosslinker.
Tada D; Tanabe T; Tachibana A; Yamauchi K
J Biosci Bioeng; 2005 Nov; 100(5):551-5. PubMed ID: 16384795
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable and pH-sensitive hydrogels for cell encapsulation and controlled drug release.
Wu DQ; Sun YX; Xu XD; Cheng SX; Zhang XZ; Zhuo RX
Biomacromolecules; 2008 Apr; 9(4):1155-62. PubMed ID: 18307310
[TBL] [Abstract][Full Text] [Related]
15. Bone-specific delivery and sustained release of diclofenac, a non-steroidal anti-inflammatory drug, via bisphosphonic prodrug based on the Osteotropic Drug Delivery System (ODDS).
Hirabayashi H; Takahashi T; Fujisaki J; Masunaga T; Sato S; Hiroi J; Tokunaga Y; Kimura S; Hata T
J Control Release; 2001 Jan; 70(1-2):183-91. PubMed ID: 11166418
[TBL] [Abstract][Full Text] [Related]
16. Impact of PAMAM G2 and G6 dendrimers on bovine serum albumin (fatty acids free and loaded with different fatty acids).
Shcharbin D; Ottaviani MF; Cangiotti M; Przybyszewska M; Zaborski M; Bryszewska M
Colloids Surf B Biointerfaces; 2008 May; 63(1):27-33. PubMed ID: 18068340
[TBL] [Abstract][Full Text] [Related]
17. A family of hierarchically self-assembling linear-dendritic hybrid polymers for highly efficient targeted gene delivery.
Wood KC; Little SR; Langer R; Hammond PT
Angew Chem Int Ed Engl; 2005 Oct; 44(41):6704-8. PubMed ID: 16173106
[No Abstract] [Full Text] [Related]
18. Molecular engineering of dendritic polymers and their application as drug and gene delivery systems.
Paleos CM; Tsiourvas D; Sideratou Z
Mol Pharm; 2007; 4(2):169-88. PubMed ID: 17222053
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and preliminary evaluation in vitro of novel naproxen-dendritic peptide conjugates.
Ouyang L; Zhang J; Pan J; Yan L; Guo L
Drug Deliv; 2009 Aug; 16(6):348-56. PubMed ID: 19606949
[TBL] [Abstract][Full Text] [Related]
20. Designing proteins for bone targeting.
Gittens SA; Bansal G; Zernicke RF; Uludağ H
Adv Drug Deliv Rev; 2005 May; 57(7):1011-36. PubMed ID: 15876401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
